Bristol-Myers to invest in Compugen, collaborate in clinical trials

Monday, October 15, 2018 - 01:23 in Health & Medicine

Bristol-Myers Squibb Co and Israel's Compugen said on Thursday they will collaborate in clinical trials for patients with advanced solid tumors.

Read the whole article on Reuters:Science

More from Reuters:Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net